![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Abstract
The present study was aimed to develop a matrix-type transdermal formulation of pentazocine using mixed polymeric grades of Eudragit RL/RS. The possible interaction between drug and polymer used were characterized by FTIR, DSC and X-RD. X-RD study indicates a change of state of drug from crystalline to amorphous in the matrix films prepared. The matrix transdermal films of pentazocine were evaluated for physical parameters and in vitro dissolution characteristic using Cygnus’ sandwich patch holder. Irrespective of the grades of Eudragit polymer used, the thickness and weight per patch were similar. In vitro dissolution study revealed that, with an increase in the proportion of Eudragit RS (slightly permeable) type polymer, dissolution half life (t50%) increases and dissolution rate constant value decreases. Selected formulations were chosen for these pharmacokinetic studies in healthy rabbits. The relevance of difference in the in vitro dissolution rate profile and pharmacokinetic parameters (Cmax, tmax, AUC(s), t1/2, Kel, and MRT) were evaluated statistically. In vitro dissolution profiles (DRC and t50%) and pharmacokinetic parameters showed a significant difference between test products (P < 0.01). Quantitatively good correlation was found between the percentage of drug absorbed from the transdermal patches and AUC(s).
Acknowledgements
The authors wish to thank Vice-Chancellor, Birla Institute of Technology, Mesra, for providing the facilities and encouragement. The helpful discussions of Dr D. Sasmal, Dr G.M. Panpalia and Mrs S.M. Verma are highly acknowledged. Ashok R. Chandak gratefully acknowledges financial support in the form of a Senior Research Fellowship provided during the period of study by University Grants Commission, New Delhi, India UGC Grant F.No. 7-8/2004 (SR).